[1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. DOI: 10.3322/caac.21660.
[2] Staff NP, Grisold A, Grisold W, et al. Chemotherapy-induced peripheral neuropathy: a current review[J]. Ann Neurol, 2017, 81(6):772-781. DOI: 10.1002/ana.24951.
[3] Miller KD, Nogueira L, Devasia T, et al. Cancer treatment and survivorship statistics, 2022[J]. CA Cancer J Clin, 2022, 72(5):409-436. DOI: 10.3322/caac.21731.
[4] Seretny M, Currie GL, Sena ES, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis[J]. Pain, 2014, 155(12):2461-2470. DOI: 10.1016/j.pain.2014.09.020.
[5] Desforges AD, Hebert CM, Spence AL, et al. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update[J]. Biomed Pharmacother, 2022, 147:112671. DOI: 10.1016/j.biopha.2022.112671.
[6] 赵顺莹,徐哲,刘婷,等.癌症患者对化疗致周围神经病变体验质性研究的系统评价[J].护理管理杂志,2020,20(5):339-344. DOI:10.3969/j.issn.1671-315x.2020.05.008.
[7] Burgess J, Ferdousi M, Gosal D, et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment[J]. Oncol Ther, 2021, 9(2):385-450. DOI: 10.1007/s40487-021- 00168-y.
[8] Nicolini C, Fahnestock M, Gibala MJ, et al. Understanding the neurophysiological and molecular mechanisms of exercise-induced neuroplasticity in cortical and descending motor pathways: where do we stand?[J]. Neuroscience, 2021, 457:259-282. DOI: 10.1016/j.neuroscience.2020.12.013.
[9] Nuñez de Arenas-Arroyo S, Cavero-Redondo I, Torres-Costoso A, et al. Effects of exercise interventions to reduce chemotherapy-induced peripheral neuropathy severity: a meta-analysis[J]. Scand J Med Sci Sports, 2023, 33(7):1040-1053. DOI: 10.1111/sms.14360.
[10] 张莹,李之华,刘子晗.运动疗法防治肿瘤患者化疗所致周围神经病变效果的Meta分析[J].现代临床护理,2023,22(5):72-79. DOI:10.3969/j.issn.1671-8283.2023.05.011.
[11] 张方圆,沈傲梅,曾宪涛,等.系统评价方法学质量评价工具AMSTAR 2解读[J].中国循证心血管医学杂志,2018,10(1):14-18. DOI:10.3969/j.issn.1674-4055.2018.01.03.
[12] 陶欢,杨乐天,平安,等.随机或非随机防治性研究系统评价的质量评价工具AMSTAR2解读[J].中国循证医学杂志,2018,18(1):101-108. DOI:10.7507/1672-2531. 201711005.
[13] 陈耀龙,姚亮,Susan Norris,等.GRADE在系统评价中应用的必要性及注意事项[J].中国循证医学杂志,2013,13(12):1401-1404. DOI:10.7507/1672-2531.20130240.
[14] Howard Balshem, Mark Helfanda, Holger J. Schunemann, 等.GRADE指南:Ⅲ.证据质量分级[J].中国循证医学杂志,2011,11(4):451-455. DOI:10.3969/j.issn.1672-2531. 2011.04.017.
[15] Gordon H. Guyatt, Andrew D. Oxman, Gunn Vist, 等.GRADE指南:Ⅳ.证据质量分级——研究的局限性(偏倚风险)[J].中国循证医学杂志,2011,11(4):456-463. DOI:10.3969/j.issn.1672-2531.2011.04.018.
[16] Gordon H.Guyatt, Andrew D.Oxman, Victor Montori, 等.GRADE指南:Ⅴ.证据质量评价——发表偏倚[J].中国循证医学杂志,2011,11(12):1430-1434. DOI:10.3969/j.issn.1672-2531.2011.12.015.
[17] Gordon Guyatt, Andrew D.Oxman, Regina Kunz, 等.GRADE指南:Ⅵ.证据质量评价——不精确性(随机误差)[J].中国循证医学杂志,2011,11(12):1435-1443. DOI:10.3969/j.issn.1672-2531.2011.12.016.
[18] Gordon H.Guyatt, Andrew D.Oxman, Regina Kunz, 等.GRADE指南:Ⅶ.证据质量评价——不一致性[J].中国循证医学杂志,2011,11(12):1444-1451. DOI:10.3969/j.issn.1672-2531.2011.12.017.
[19] Gordon Guyatt, Andrew D.Oxman, Regina Kunz, 等.GRADE指南:Ⅷ.证据质量评价——间接性[J].中国循证医学杂志,2011,11(12):1452-1458. DOI:10.3969/j.issn.1672-2531. 2011.12.018.
[20] Guo S, Han W, Wang P, et al. Effects of exercise on chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review and meta-analysis[J]. J Cancer Surviv, 2023, 17(2):318-331. DOI: 10.1007/s11764-022-01182-3.
[21] Dixit S, Tapia V, Sepúlveda C, et al. Effectiveness of a therapeutic exercise program to improve the symptoms of peripheral neuropathy during chemotherapy: systematic review of randomized clinical trials[J]. Life (Basel), 2023, 13(2):262. DOI: 10.3390/life13020262.
[22] Brownson-Smith R, Orange ST, Cresti N, et al. Effect of exercise before and/or during taxane-containing chemotherapy treatment on chemotherapy-induced peripheral neuropathy symptoms in women with breast cancer: systematic review and meta-analysis[J]. J Cancer Surviv, 2023. DOI: 10.1007/s11764-023-01450-w.
[23] Lopez-Garzon M, Cantarero-Villanueva I, Postigo-Martin P, et al. Can physical exercise prevent chemotherapy-induced peripheral neuropathy in patients with cancer? A systematic review and meta-analysis[J]. Arch Phys Med Rehabil, 2022, 103(11):2197-2208. DOI: 10.1016/j.apmr.2022.02.008.
[24] Lin WL, Wang RH, Chou FH, et al. The effects of exercise on chemotherapy-induced peripheral neuropathy symptoms in cancer patients: a systematic review and meta-analysis[J]. Support Care Cancer, 2021, 29(9):5303-5311. DOI: 10.1007/s00520-021-06082-3.
[25] Tanay MAL, Armes J, Moss-Morris R, et al. A systematic review of behavioural and exercise interventions for the prevention and management of chemotherapy-induced peripheral neuropathy symptoms[J]. J Cancer Surviv, 2023, 17(1):254-277. DOI: 10.1007/s11764-021- 00997-w.
[26] Duregon F, Vendramin B, Bullo V, et al. Effects of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: a systematic review[J]. Crit Rev Oncol Hematol, 2018, 121:90-100. DOI: 10.1016/j.critrevonc.2017.11.002.
[27] Park SB, Goldstein D, Krishnan AV, et al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis[J]. CA Cancer J Clin, 2013, 63(6):419-437. DOI: 10.3322/caac.21204.
[28] 陈思诺,李珍,陈露娜,等.化疗致周围神经病变病人报告结局评估工具研究进展[J].全科护理,2023,21(24):3350-3354. DOI:10.12104/j.issn.1674-4748.2023.24.009.
[29] Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update[J]. J Clin Oncol, 2020, 38(28):3325-3348. DOI: 10.1200/JCO.20.01399.
[30] 中国中西医结合疼痛学会,中国抗癌协会中西医整合专业委员会,中国中医药研究促进会.化疗所致周围神经病理性疼痛中西医诊治专家共识[J].中华肿瘤防治杂志,2021,28(23):1761-1767,1779. DOI:10.16073/j.cnki.cjcpt.2021. 23.01.
|